Dennis E. Hourcade
Washington University School of Medicine
Department of Medicine
Division of Rheumatology
St. Louis
USA
Name/email consistency: high
- Properdin and complement activation: a fresh perspective. Hourcade, D.E. Curr. Drug. Targets (2008)
- The role of properdin in the assembly of the alternative pathway C3 convertases of complement. Hourcade, D.E. J. Biol. Chem. (2006)
- Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb. Hourcade, D.E., Mitchell, L., Kuttner-Kondo, L.A., Atkinson, J.P., Medof, M.E. J. Biol. Chem. (2002)
- Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding. Hourcade, D.E., Mitchell, L.M., Oglesby, T.J. J. Immunol. (1999)
- Decay acceleration of the complement alternative pathway C3 convertase. Hourcade, D.E., Mitchell, L.M., Medof, M.E. Immunopharmacology (1999)
- A conserved element in the serine protease domain of complement factor B. Hourcade, D.E., Mitchell, L.M., Oglesby, T.J. J. Biol. Chem. (1998)
